ONWARD® Medical Reaf
ONWARD® Medical Reaffirms Guidance, Shares 2024 Strategic Priorities, and Releases Unaudited Q4 Financial Highlights
March 15, 2024 02:30 ET | ONWARD Medical NV
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Company expects to commercialize its ARC-EX®...
ONWARD versterkt man
ONWARD versterkt management met kernfuncties in Klinische & Regelgevende en Marketingafdelingen
March 15, 2024 02:30 ET | ONWARD Medical NV
EINDHOVEN, Nederland, LAUSANNE, Zwitserland & BOSTON, MA, VS, March 15, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), het medische technologiebedrijf dat innovatieve therapieën...
ONWARD renforce son
ONWARD renforce son management avec des nominations clés dans le domaine clinique et réglementaire et en marketing
March 15, 2024 02:30 ET | ONWARD Medical NV
EINDHOVEN, Pays-Bas, LAUSANNE, Suisse, et BOSTON, MA, Etats-Unis, 15 mars 2024 (GLOBE NEWSWIRE) -- ONWARD Medical SA (Euronext: ONWD), société de technologie médicale créant des thérapies innovantes...
ONWARD verstärkt Füh
ONWARD verstärkt Führungsteam auf Schlüsselpositionen in den Bereichen Clinical & Regulatory sowie Marketing
March 15, 2024 02:30 ET | ONWARD Medical NV
EINDHOVEN, Niederlande, LAUSANNE, Schweiz und BOSTON, MA, March 15, 2024 (GLOBE NEWSWIRE) -- Das Medizintechnikunternehmen ONWARD Medical N.V. (Euronext: ONWD), das innovative Therapien zur...
ONWARD® Reports Q3 B
ONWARD® Reports Q3 Business Update and Year-To-Date Highlights
November 16, 2023 01:30 ET | ONWARD Medical NV
EINDHOVEN, the Netherlands, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Completing activities required for ARC-EX® FDA submission     Expanded HemON Study as precursor to ARC-IM® Empower BP pivotal...
ONWARD versterkt man
ONWARD versterkt management met kernfuncties in Klinische & Regelgevende en Marketingafdelingen
November 16, 2023 01:30 ET | ONWARD Medical NV
EINDHOVEN, Nederland, LAUSANNE, Zwitserland & BOSTON, MA, VS, Nov. 16, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), het medische technologiebedrijf dat innovatieve therapieën...
ONWARD renforce son
ONWARD renforce son management avec des nominations clés dans le domaine clinique et réglementaire et en marketing
November 16, 2023 01:30 ET | ONWARD Medical NV
EINDHOVEN, Pays-Bas, LAUSANNE, Suisse, et BOSTON, MA, Etats-Unis, 16 nov. 2023 (GLOBE NEWSWIRE) -- ONWARD Medical SA (Euronext: ONWD), société de technologie médicale créant des thérapies innovantes...
ONWARD verstärkt Füh
ONWARD verstärkt Führungsteam auf Schlüsselpositionen in den Bereichen Clinical & Regulatory sowie Marketing
November 16, 2023 01:30 ET | ONWARD Medical NV
EINDHOVEN, Niederlande, LAUSANNE, Schweiz und BOSTON, MA, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Das Medizintechnikunternehmen ONWARD Medical N.V. (Euronext: ONWD), das innovative Therapien zur...
Nature Medicine Publ
Nature Medicine Publication Highlights Potential for ONWARD® ARC Therapy™ to Improve Mobility After Parkinson’s Disease
November 06, 2023 12:13 ET | ONWARD Medical NV
EINDHOVEN, the Netherlands, Nov. 06, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore...
ONWARD versterkt man
ONWARD versterkt management met kernfuncties in Klinische & Regelgevende en Marketingafdelingen
November 06, 2023 12:13 ET | ONWARD Medical NV
EINDHOVEN, Nederland, LAUSANNE, Zwitserland & BOSTON, MA, VS, Nov. 06, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), het medische technologiebedrijf dat innovatieve therapieën...